| Dr Naji Chaaya Salloum, MD | |
|
1 Barnes Jewish Hospital Plz, Saint Louis, MO 63110-1003 | |
| (314) 362-2462 | |
| Not Available |
| Full Name | Dr Naji Chaaya Salloum |
|---|---|
| Gender | Male |
| Speciality | Psychiatry & Neurology - Psychiatry |
| Location | 1 Barnes Jewish Hospital Plz, Saint Louis, Missouri |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1023458189 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 2084P0800X | Psychiatry & Neurology - Psychiatry | 2013017463 (Missouri) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Dr Naji Chaaya Salloum, MD 1 Barnes Jewish Hospital Plz, Saint Louis, MO 63110-1003 Ph: (314) 362-2462 | Dr Naji Chaaya Salloum, MD 1 Barnes Jewish Hospital Plz, Saint Louis, MO 63110-1003 Ph: (314) 362-2462 |
News Archive
AstraZeneca announced today that Health Canada has approved CRESTOR (rosuvastatin calcium) to reduce the risk of nonfatal myocardial infarction (heart attack), nonfatal stroke, and coronary artery revascularization in adult patients without documented history of cardiovascular or cerebrovascular events, but with at least two conventional risk factors for cardiovascular disease.
Golden Meditech Holdings Limited, China's leading integrated healthcare enterprise, today announced that the Group has been repurchasing its shares from the market in the month of December 2011, accumulating a total of 58,104,000 shares in December 2011, equivalent to 2.84% of the Group's total outstanding shares as of today at a weighted average price of HK$0.84 per share.
Bioengineers at the University of California San Diego have developed a cancer immunotherapy that pairs ultrasound with cancer-killing immune cells to destroy malignant tumors while sparing normal tissue.
NovaBay Pharmaceuticals, Inc., a clinical stage biotechnology company developing first-in-class, anti-infective compounds for the treatment and prevention of antibiotic-resistant infections, has reported third quarter financial results and highlighted the clinical progress of its in-house programs.
› Verified 3 days ago
Dr. Lauren Flynn, M.D. Psychiatry & Neurology Medicare: Not Enrolled in Medicare Practice Location: 231 W Lockwood Ave, Suite 202, Saint Louis, MO 63119 Phone: 314-737-4070 | |
Ryan Bradley Sondergard, D.O. Psychiatry & Neurology Medicare: Not Enrolled in Medicare Practice Location: 10018 Kennerly Rd, Saint Louis, MO 63128 Phone: 314-525-4429 | |
Dr. Antonina S Gesmundo, MD Psychiatry & Neurology Medicare: Medicare Enrolled Practice Location: 1 Jefferson Barracks Dr, Saint Louis, MO 63125 Phone: 314-894-6636 | |
Mr. Robert Harry Brady, M.D. Psychiatry & Neurology Medicare: Accepting Medicare Assignments Practice Location: 1430 Olive St, Suite 500, Saint Louis, MO 63103 Phone: 314-206-3724 Fax: 314-206-3708 | |
Dr. Marcus E Raichle, MD Psychiatry & Neurology Medicare: Not Enrolled in Medicare Practice Location: 517 S Euclid Ave, Ground Floor, Saint Louis, MO 63110 Phone: 314-362-6907 Fax: 314-747-3258 | |
Rohit Pawar, M.D. Psychiatry & Neurology Medicare: Accepting Medicare Assignments Practice Location: 10018 Kennerly Rd, Saint Louis, MO 63128 Phone: 314-525-7275 Fax: 314-525-7260 | |
Dr. Rushaniya Albeptovna Khairova, MD Psychiatry & Neurology Medicare: Accepting Medicare Assignments Practice Location: 24 S Kingshighway Blvd, Saint Louis, MO 63108 Phone: 314-286-1700 Fax: 314-286-1730 |